Dominique Stoppa‐Lyonnet

33.9k total citations · 1 hit paper
239 papers, 7.4k citations indexed

About

Dominique Stoppa‐Lyonnet is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Dominique Stoppa‐Lyonnet has authored 239 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Genetics, 112 papers in Molecular Biology and 58 papers in Cancer Research. Recurrent topics in Dominique Stoppa‐Lyonnet's work include BRCA gene mutations in cancer (130 papers), DNA Repair Mechanisms (51 papers) and Cancer Genomics and Diagnostics (41 papers). Dominique Stoppa‐Lyonnet is often cited by papers focused on BRCA gene mutations in cancer (130 papers), DNA Repair Mechanisms (51 papers) and Cancer Genomics and Diagnostics (41 papers). Dominique Stoppa‐Lyonnet collaborates with scholars based in France, United States and Germany. Dominique Stoppa‐Lyonnet's co-authors include Marc‐Henri Stern, Marion Gauthier‐Villars, Anthony Laugé, Mario Tosi, Claude Houdayer, Anne Vincent‐Salomon, Virginie Caux‐Moncoutier, Brigitte Sigal‐Zafrani, Brigitte Bressac–de Paillerets and Élodie Manié and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Dominique Stoppa‐Lyonnet

230 papers receiving 7.2k citations

Hit Papers

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers 2015 2026 2018 2022 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
    2015 467 citations Gaëlle Bougeard, Mariette Renaux‐Petel et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dominique Stoppa‐Lyonnet France 47 3.9k 3.1k 2.3k 1.9k 1.1k 239 7.4k
Sharon E. Plon United States 50 3.8k 1.0× 3.4k 1.1× 1.3k 0.6× 1.6k 0.8× 1.1k 1.0× 187 8.4k
Christophe Béroud France 41 4.2k 1.1× 1.7k 0.5× 1.7k 0.7× 1.4k 0.7× 747 0.7× 117 7.2k
Hanne Meijers‐Heijboer Netherlands 40 1.9k 0.5× 2.5k 0.8× 1.1k 0.5× 1.1k 0.5× 917 0.8× 98 4.9k
Alfons Meindl Germany 37 3.4k 0.9× 2.0k 0.7× 761 0.3× 965 0.5× 533 0.5× 76 5.7k
H. Berna Beverloo Netherlands 50 5.3k 1.4× 821 0.3× 1.7k 0.7× 1.2k 0.6× 523 0.5× 125 9.4k
Sean V. Tavtigian United States 49 9.6k 2.4× 5.9k 1.9× 4.5k 1.9× 3.6k 1.9× 2.6k 2.4× 130 15.3k
Farideh Z. Bischoff United States 35 3.1k 0.8× 1.3k 0.4× 3.4k 1.5× 1.8k 0.9× 730 0.7× 91 7.1k
David W. Yandell United States 38 3.9k 1.0× 954 0.3× 3.1k 1.3× 1.2k 0.6× 749 0.7× 67 7.0k
David Malkin Canada 54 5.6k 1.4× 2.2k 0.7× 4.6k 2.0× 3.1k 1.6× 1.3k 1.2× 226 11.5k
Paul J. Goodfellow United States 51 5.1k 1.3× 2.2k 0.7× 2.8k 1.2× 3.0k 1.5× 2.7k 2.4× 222 11.1k

Countries citing papers authored by Dominique Stoppa‐Lyonnet

Since Specialization
Citations

This map shows the geographic impact of Dominique Stoppa‐Lyonnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Stoppa‐Lyonnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Stoppa‐Lyonnet more than expected).

Fields of papers citing papers by Dominique Stoppa‐Lyonnet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Stoppa‐Lyonnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Stoppa‐Lyonnet. The network helps show where Dominique Stoppa‐Lyonnet may publish in the future.

Co-authorship network of co-authors of Dominique Stoppa‐Lyonnet

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Stoppa‐Lyonnet. A scholar is included among the top collaborators of Dominique Stoppa‐Lyonnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Stoppa‐Lyonnet. Dominique Stoppa‐Lyonnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiao, Yue, Laetitia Fuhrmann, Marie‐Gabrielle Dondon, et al.. (2025). Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile. Breast Cancer Research. 27(1). 36–36.
2.
Warcoin, Mathilde, Bruno Buecher, Lisa Golmard, et al.. (2023). First report of medulloblastoma in a patient with MUTYH ‐associated polyposis. Neuropathology and Applied Neurobiology. 49(4). e12929–e12929. 2 indexed citations
3.
4.
Girard, Elodie, Sandrine M. Caputo, Victor Renault, et al.. (2023). Adaptive nanopore sequencing to determine pathogenicity ofBRCA1exonic duplication. Journal of Medical Genetics. 60(12). 1206–1209. 11 indexed citations
5.
Brédart, Anne, Antoine De Pauw, Amélie Anota, et al.. (2022). Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study. Clinical Genetics. 102(1). 30–39. 2 indexed citations
6.
Dehainault, Catherine, Alexandre Matet, Livia Lumbroso‐Le Rouic, et al.. (2021). Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. Journal of Molecular Diagnostics. 23(12). 1714–1721. 16 indexed citations
7.
Brédart, Anne, Amélie Anota, Olivier Lareyre, et al.. (2018). Patient-Centered Care in Breast Cancer Genetic Clinics. International Journal of Environmental Research and Public Health. 15(2). 319–319. 9 indexed citations
8.
Thion, Morgane Sonia, Sophie Tézenas du Montcel, Jean‐Louis Golmard, et al.. (2016). CAG repeat size in Huntingtin alleles is associated with cancer prognosis. European Journal of Human Genetics. 24(9). 1310–1315. 17 indexed citations
9.
Curtit, Elsa, Vanessa Benhamo, Nadège Gruel, et al.. (2015). First description of a sporadic breast cancer in a woman with BRCA1 germline mutation. Oncotarget. 6(34). 35616–35624. 7 indexed citations
10.
Bougeard, Gaëlle, Mariette Renaux‐Petel, Jean‐Michel Flaman, et al.. (2015). Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers. Journal of Clinical Oncology. 33(21). 2345–2352. 467 indexed citations breakdown →
11.
Popova, Tatiana, Élodie Manié, Guillaume Rieunier, et al.. (2012). Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation. Cancer Research. 72(21). 5454–5462. 418 indexed citations
12.
Ceccaldi, Raphaël, Delphine Briot, Jérôme Larghero, et al.. (2010). Spontaneous abrogation of the G2 DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients. Journal of Clinical Investigation. 121(1). 184–194. 49 indexed citations
13.
Amor-Guéret, Mounira, Anthony Laugé, Rosine Onclercq-Delic, et al.. (2008). Three New BLM Gene Mutations Associated with Bloom Syndrome. Genetic Testing. 12(2). 257–261. 11 indexed citations
14.
Stoppa‐Lyonnet, Dominique & Gilbert Lenoir. (2005). Prédispositions génétiques aux cancers : actualités et perspectives en 2005. médecine/sciences. 21(11). 962–968. 2 indexed citations
15.
Hughes, David J., Isabelle Coupier, Laure Barjhoux, et al.. (2004). Analysis of breast cancer risk modifying candidate genes in BRCA1 and BRCA2 mutation carriers. Cancer Research. 64. 301–301. 2 indexed citations
16.
Stoppa‐Lyonnet, Dominique, et al.. (2003). Testing Participation in BRCA1/2 -Positive Families: Initiator Role of Index Cases. Genetic Testing. 7(3). 225–233. 55 indexed citations
17.
Morrison, Patrick J., C. M. Steel, N. C. Nevin, et al.. (2000). Insurance considerations for individuals with a high risk of breast cancer in Europe:Some recommendations. Research Explorer (The University of Manchester). 3 indexed citations
18.
Janin, Nicolas, Nadine Andrieu, Katia Ossian, et al.. (1999). Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. British Journal of Cancer. 80(7). 1042–1045. 78 indexed citations
19.
Sobol, Hagay, Yves‐Jean Bignon, Catherine Bonaïti, et al.. (1999). Four Years Analysis of Cancer Genetic Clinics Activity in France from 1994 to 1997: A Survey on 801 Patients. Disease Markers. 15(1-3). 15–29. 12 indexed citations
20.
Essioux, Laurent, Olga M. Sinilnikova, François Eisinger, et al.. (1998). Marker segregation information in breast/ovarian cancer genetic counseling: Is it still useful?. American Journal of Medical Genetics. 79(3). 175–183. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon E. Plon Breakdown of academic impact, for papers by Christophe Béroud Breakdown of academic impact, for papers by Hanne Meijers‐Heijboer Breakdown of academic impact, for papers by Alfons Meindl Breakdown of academic impact, for papers by H. Berna Beverloo Breakdown of academic impact, for papers by Sean V. Tavtigian Breakdown of academic impact, for papers by Farideh Z. Bischoff Breakdown of academic impact, for papers by David W. Yandell Breakdown of academic impact, for papers by David Malkin Breakdown of academic impact, for papers by Paul J. Goodfellow
Rankless by CCL
2026